SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-138339
Filing Date
2020-05-11
Accepted
2020-05-11 08:32:03
Documents
3
Period of Report
2020-05-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d897341d8k.htm 8-K 24880
2 EX-99.1 d897341dex991.htm EX-99.1 9259
3 GRAPHIC g897341g0510094234138.jpg GRAPHIC 8440
  Complete submission text file 0001193125-20-138339.txt   47110
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19879 | Film No.: 20862755
SIC: 2834 Pharmaceutical Preparations